International clinical practice guideline on the use of traditional Chinese medicine for ulcerative colitis by Board of Specialty Committee of Digestive System Disease of World Federation of Chinese Medicine Societies (2023)
Capital Med Univ, Beijing Hosp Tradit Chinese Med, Digest Dis Ctr, Beijing, Peoples R China
通讯作者
Zhang, Shengsheng
来源期刊
Phytother Res
ISSN
0951-418X
EISSN
1099-1573
出版日期
2023-12-01
卷号
38
期号
2
页码
970-999
摘要
Ulcerative colitis (UC), a chronic and nonspecific inflammatory disease of the intestine, has become a prevalent global health concern. This guideline aims to equip clinicians and caregivers with effective strategies for the treatment and management of adult UC patients using traditional Chinese medicine (TCM). The guideline systematically evaluated contemporary evidence through the Grading of Recommendations Assessment, Development, and Evaluation framework. Additionally, it incorporated insights from ancient Chinese medical sources, employing the evidence grading method found in traditional TCM literature. The development process involved collaboration with multidisciplinary experts and included input from patients with UC. The guideline, based on a comprehensive review of available evidence, present 40 recommendations. They offer a condensed overview of TCM's role in understanding the pathogenesis, diagnosis, and treatment of UC, along with an assessment of the efficacy of various TCM-based treatments. TCM exhibits promising outcomes in the treatment of UC. However, to establish its efficacy conclusively, further high-quality clinical studies on TCM for UC are essential.
This study was supported by the National Key R&D Program of China (No. 2019YFC1712000) and the National Natural Science Foundation of China (Nos 81973764 and 82174304), but independent of them.
